In response to Body letter to the editor regarding "safety of intravenous and oral bisphosphonates and compliance with dosing regimens". Oncologist. 2005 May;10(5):318-9. (correspondence) Conte P, Guarneri V. In response to Jackson letter to the editor regarding safety of intravenous and oral bisphosphonates and compliance with dosing regimens". Oncologist. 2005 May;10(5):315-6. (correspondence)

The Issue of Renal Safety of Zoledronic Acid from a Nephrologist's Point of View

CONTE, PIERFRANCO;GUARNERI, VALENTINA;
2005

Abstract

In response to Body letter to the editor regarding "safety of intravenous and oral bisphosphonates and compliance with dosing regimens". Oncologist. 2005 May;10(5):318-9. (correspondence) Conte P, Guarneri V. In response to Jackson letter to the editor regarding safety of intravenous and oral bisphosphonates and compliance with dosing regimens". Oncologist. 2005 May;10(5):315-6. (correspondence)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11577/2684031
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 23
social impact